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ABSTRACT
The degradome is defined as the complete set of
proteases present in an organism. The recent avail-
ability of whole genomic sequences from multiple
organisms has led us to predict the contents of
the degradomes of several mammalian species.
To ensure the fidelity of these predictions, our meth-
ods have included manual curation of individual
sequences and, when necessary, direct cloning
and sequencing experiments. The results of these
studies in human, chimpanzee, mouse and rat
have been incorporated into the Degradome data-
base, which can be accessed through a web inter-
face at http://degradome.uniovi.es. The annotations
about each individual protease can be retrieved
by browsing catalytic classes and families or by
searching specific terms. This web site also pro-
vides detailed information about genetic diseases
of proteolysis, a growing field of great importance
for multiple users. Finally, the user can find addi-
tional information about protease structures, pro-
tease inhibitors, ancillary domains of proteases
and differences between mammalian degradomes.
INTRODUCTION
Proteases are deﬁned as hydrolytic enzymes acting
on peptide bonds, in a process termed proteolysis. The
biological signiﬁcance of proteolysis has driven the evolu-
tionary invention of multiple, extremely diverse classes
and families of proteases. Thus, diﬀerent proteases are
known to play key roles in multiple biological processes,
including cell cycle progression, diﬀerentiation and migra-
tion, morphogenesis and tissue remodelling, neuronal
outgrowth, haemostasis, wound healing, immunity, angio-
genesis and apoptosis (1). The importance of proteolysis is
also apparent in the numerous pathological conditions
related to alterations in proteases, including cancer,
arthritis, progeria and neurodegenerative and cardiovas-
cular diseases (1–6). The extensive biological and patho-
logical implications of this large set of proteins with
a common biochemical function led to the concept of
proteases as a distinct subset of the proteome. Thus, the
degradome of an organism was deﬁned as the complete set
of proteases in that organism (7).
The deﬁnition of degradome naturally led to the devel-
opment of degradomics as a new experimental ﬁeld which
includes all genomic and proteomic approaches for the
identiﬁcation and characterization of proteases that are
present in an organism. The completion of multiple
genome projects has been instrumental in the advance of
degradomics by allowing researchers to extend the degra-
domes of several species in silico from known protease
sequences. While several computer programs allow the
automatic prediction of genes based on similarity, a reli-
able prediction still requires manual curation by trained
researchers (8). The reasons for this limitation include
the diﬃculty to detect small or dissimilar exons as well
as the occurrence of occasional sequencing errors.
Indeed, the analysis of a large set of genes is likely to
require manual inspection of sequencing traces and clon-
ing and re-sequencing experiments for some of the genes.
Additionally, orthology or paralogy assignment of pro-
tease genes between human and other animal models
also requires the supervision of expert curators. We have
used this manual procedure to predict the degradomes of
human, mouse, rat, chimpanzee and platypus (9–12).
Furthermore, our continued eﬀort in degradomics has
led us to mine the literature and annotate known relation-
ships between protease alterations and hereditary diseases.
Since proteases make up promising drug development tar-
gets (13–16) and clinical markers (17–19), this compilation
may prove very useful to researchers in diﬀerent ﬁelds of
human pathology. Likewise, this information on diseases
of proteolysis represents a useful resource to determine
the utility and limitations of diverse animal models to
recapitulate certain human diseases.
Here we report the Degradome database, which
contains the results of the manual annotation of every
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protease gene in the genomes of human, chimpanzee,
mouse and rat, along with relationships between protease
alterations and hereditary diseases. This database comple-
ments existing databases devoted to proteases, by provid-
ing a diﬀerent focus. Namely, the database ProLysED
(20) is devoted to proteases in prokaryotes, whereas our
target organisms are mammals. On the other hand,
CutDB (21) focuses on annotation of individual proteoly-
tic events, both actual and predicted, rather than on the
proteases themselves. Finally, MEROPS (22) is a compre-
hensive and excellent database which relies on large-scale
experiments and automatic annotation. However, a
number of entries in this database correspond to pseudo-
genes or sequences derived from retroviral elements which
do not code for any functional proteolytic enzyme. By
contrast, our Degradome database, while less comprehen-
sive in the number of species, relies on manual annotation
and exhaustive curation of genes on an individual basis.
In multiple cases, this informatic work is supported by
direct cloning and sequencing experiments (23–27).
Furthermore, our emphasis in diseases adds important
information on the pathological relevance of some pro-
teases, which is not directly available in other databases.
The Degradome database is aimed at researchers look-
ing for speciﬁc information about mammalian proteases
and protease families. Additionally, we have incorporated
features intended to help non-experienced users who want
to learn about the degradome. These features include
selected publications and interactive 3D structures that
can be displayed and manipulated with Acrobat reader
and thus do not need specialized software.
DATABASE ACCESS
Annotation of individual proteases
The Degradome database contains information about
570 human, 568 chimpanzee, 651 mouse and 641 rat
proteases. All of these proteases can be grouped into ﬁve
catalytic classes, depending on the key residue for their
catalytic mechanism. Accordingly, the database infor-
mation is structured in ﬁve tables, containing aspartyl-,
cysteine-, metallo-, serine- and threonine-proteases.
Each table displays the name of the family using the
MEROPS classiﬁcation system, the name of each protease
and the gene symbol for the protease in each species
(Figure 1A). Orthologous genes for each individual organ-
ism are easily identiﬁed, as well as those pseudogenes for
which a functional protease gene is present in at least one
of the selected mammalian species. In addition to this
summarized view of the tables, every ﬁeld contains a
link providing additional information. Thus, the name
of the family leads to a diﬀerent web page with selected
publications intended as a primer for users who wish to
gather speciﬁc information about that family of proteases.
When available, this web page also contains a link to
a description of the structural features of the family
(see ‘selected structures’).
On the other hand, the protease-speciﬁc links open
‘popup’ tables with information about each protease
(Figure 1A). Since this information is retrieved via
a dynamic script, the user will be oﬀered a link to a
static table if Javascript is not enabled in the client brow-
ser. The table from the protease name ﬁeld displays
the MEROPS code with a hyperlink to the corresponding
MEROPS web page and the predicted cellular localization
of the protease. Finally, each of the species-speciﬁc cells
provides external links to related entries in other data-
bases, i.e. NCBI (28) and Ensembl (29)—genomic locus,
gene status (gene/pseudogene in the indicated species) and
proteolytic activity, whether the protein encoded by this
gene is an active protease or an inactive protease homo-
logue due to changes in key catalytic residues. In addition,
if the protease is known to be mutated in a hereditary
disease, this information is provided, along with a link
to the OMIM database entry describing the disease (30).
Search engine
The Degradome database can also be queried using the
speciﬁc search engine (http://degradome.uniovi.es/search.
html). This option lets the user ﬁnd proteases which meet
user-deﬁned criteria such as the presence or absence in
selected species, the localization within a speciﬁc chromo-
somal locus, or the existence of mutations which lead
to human hereditary diseases (Figure 1B). To make this
process intuitive, all of the possibilities are listed in several
‘dropdown boxes’, so that every query is expressed as a
meaningful simple sentence. Users can combine several
searches to easily perform moderately complex queries.
Thus, once a search has been ﬁnished, it can be reﬁned
with a second search by setting the ﬁrst box to ‘keep’.
This is equivalent to a logical ‘AND’ between both queries.
The results of the second search can also be added to the
results of the ﬁrst search—logical ‘OR’—or removed from
the results of the ﬁrst search—logical ‘AND NOT’.
As an example, to ﬁnd which human proteases are
involved in a disease and located in human chromosome
12q, we can ﬁrst set the query boxes to ‘Search for
proteases containing 12q in the ﬁeld Locus of Human’.
This will retrieve 21 proteases. Then, we can rearrange
the query boxes to ‘Keep proteases mutated in a disease’,
which will narrow the results to a single hit.
Hereditary diseases of proteolysis
The information about mutated proteases in hereditary
diseases has been compiled into a table (http://degra
dome.uniovi.es/diseases.html), so that users speciﬁcally
interested in this subject do not need to browse or search
the individual annotations. At its present form, the table of
degradome-related genetic diseases contains 77 proteases,
with information about gene locus, mode of inheritance,
pathologic protease alteration (gain/loss of proteolytic
activity) and availability of described animal models con-
taining the same protease anomaly (Figure 1C). A link
to related OMIM entries is also provided.
To our knowledge, this is the ﬁrst summary of the rela-
tionships between degradomics and pathology. The large
number of protease alterations related to diverse diseases
highlights the signiﬁcance of the degradome to maintain
a correct physiological balance. It must be noted that
this summary does not include the multiple examples of
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non-hereditary diseases in which proteases are known to
play an important role as a consequence of alterations
in their spatio-temporal patterns of expression (2–6).
Notably, the degradome database has also demonstrated
its usefulness in the analysis of proteases associated with
cancer (31).
Selected structures
Proteases represent important pharmacological targets for
diﬀerent human pathologies. Therefore, an important
aspect of protease research has been to know the mecha-
nism of action of these enzymes by determining the 3D
structure of individual proteases. In this regard, we have
prepared 22 web pages showing structural features of
representative members of diﬀerent protease families
(Figure 1D). These web pages can be accessed from
an index (http://degradome.uniovi.es/structures.html) or
from the ‘family’ ﬁeld in the tables of individual annota-
tions. The ﬁgures show the secondary structure elements
as ribbons, with catalytic side chains and inhibitors. The
user can freely interact with the representations, rotating
and moving the structure, zooming in or out, and hiding
or showing parts of the protease. These capabilities
are provided through portable document format (pdf)
ﬁles, which are also freely available for download.
These structures have been selected to present a general
view of the multiple folds that can be found in the degra-
dome. Most of the structures include a speciﬁc inhibitor
interacting with the catalytic residues. In contrast, three
structures from diﬀerent catalytic classes have been chosen
which display proteases in their active form. In these
structures, the user can display schematics explaining
the putative catalytic mechanisms of cysteine-proteases
Figure 1. Main features of the Degradome database. (A) Individual annotations of aspartyl proteases. The ﬁrst column contains the name of the family,
with a hyperlink to a web page where the user can ﬁnd related selected publications and structures. The second column contains the name of each protease,
with a hyperlink which opens a ‘popup’ table with further general information—in this example, ‘presenilin 1’. The rest of the columns show the symbol of
each protease in each organism, with a hyperlink which opens a ‘popup’ table with species-speciﬁc information—in this example, ‘human presenilin 1’.
Pseudogenes are shown over a ‘pink background’. Proteases absent in a species are shown as ‘empty grey cells’. (B) Search interface. ‘Dropdown boxes’
are used to deﬁne the query. In this example, 26 proteases have been found to contain the term ‘mmp’ in any ﬁeld of any species. The ‘yellow boxes’
have been added to show additional possibilities for each ﬁeld of the query deﬁnition. The search is case-insensitive by default, but an ‘option box’ exists
to make the search case-sensitive. Searches can be combined by ‘keeping’ results from a previous search, ‘adding’ results to a previous search or ‘removing’
results from a previous search. (C) Mutated proteases in human hereditary diseases. Each row contains information about gene locus, disease
name, OMIM entry, mode of inheritance, pathologic protease alteration (activity gain or loss), and availability of animal models containing the
same protease anomaly. (D) Interactive structure representation of ‘thimet oligopeptidase’, from the M03 metalloprotease family. The structure
can be rotated, moved, and zoomed. A ‘discontinuous bar’ shows the coordination of the catalytic water molecule with the zinc ion (‘golden sphere’).
An ‘arrow’ shows the electrostatic interaction between the catalytic glutamic acid side chain and the catalytic water molecule.
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(C26 family), serine-proteases (S10 family) and metallo-
proteases (M03 family).
Additional contents
In addition to the Degradome database, the web site also
oﬀers several summaries of the characteristics of mam-
malian degradomes. Thus, a static table listing human,
mouse and rat protease inhibitors can be found at
http://degradome.uniovi.es/inhibitors.html. A count of
proteases in these species, itemized by catalytic class,
is shown at http://degradome.uniovi.es/numbers.html.
These numbers should not be considered deﬁnitive and
are likely to be expanded as novel catalytic classes are
discovered and added to the Degradome database.
Additionally, since most proteases display a series of
non-proteolytic domains linked to the catalytic unit,
we have also prepared a ﬁgure showing the diﬀerent ancil-
lary domains present in proteases (http://degradome.
uniovi.es/domains.html). Finally, we have incorporated
a ﬁgure summarizing the diﬀerences between human and
mouse degradomes (http://degradome.uniovi.es/hmd.
html). This ﬁgure is displayed as a static image and also
as an interactive pdf ﬁle.
Implementation
The database with the annotations of individual prote-
ases has been stored in ﬁve extensible markup language
(XML) ﬁles, one for each catalytic class. These XML ﬁles
are freely available upon request. Individual anno-
tation tables access the corresponding XML ﬁles through
Javascript. Therefore, if the browser lacks Javascript
or Javascript is blocked, the user is oﬀered a link to a
static table displaying all of the information at once.
On the other hand, several interactive features—i.e.
‘selected structures’ and ‘human/mouse degradome diﬀer-
ences’—are oﬀered as pdf ﬁles. Thus, the user does not
need any plugins or speciﬁc software to manipulate these
ﬁgures, only Adobe Reader v7.0 or higher. The web pages
contain an external link to a web page where the user can
download the last version of Adobe Reader. It must be
noted that Microsoft Internet Explorer treats embedded
pdf ﬁles as ActiveX content, which may be blocked in
the browser. If this happens, the user can download the
pdf ﬁle and access its contents locally.
CONCLUSION AND FUTURE DIRECTION
We have developed a database devoted to the degradome
in several mammalian species, which is freely available
through a web interface. Notably, this database contains
information about the involvement of proteases in genetic
diseases. The features provided by the degradome data-
base are useful for researchers in the degradomics ﬁeld,
as well as for researchers working on individual proteases
and protease families. It will also be of special interest to
researchers working with animal models, as this database
provides a highly curated repertoire of orthologous genes
between human, mouse and rat. Likewise, the degra-
dome database shows diﬀerences in protease genes
between these organisms due to the selective expansion
of a series of protease coding genes in rodents, which
might hamper the use of these animal models to study
certain human proteases.
Our future plans include the extension of the database
to other species. At this moment, we are in the process
of adding the degradome of platypus. Other species we
are currently studying include non-mammalian metazoa
which may provide additional clues about the evolution
of proteases. Finally, we plan to oﬀer new features which
will allow users to search for sequences and motifs in
the degradome.
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